Consistent with these results, our analysis of RNA-seq expression profiles confirmed that the gene signature related with the luminal status is negatively enriched in the tumors expressing shRNA for Bmpr1a (Figure 5E and Figure 5—figure supplement 1G), whereas tumor expressing control shRNA showed standard signature of luminal-like subtype. The gene discussed is BMPR1A; the disease is neoplasm.